A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients.
1University of Vienna, Vienna, Austria; 2Hospital Erasme, Brussels, Belgium; 3St. Vincent's Hospital, Sydney, Australia; 4University of Ziekenhuizen, Leuven, Belgium; 5University of Lausanne, Lausanne, Switzerland; 6University of Geneva, Geneva, Switzerland; 7University of Kiel, Kiel, Germany; 8University of Grosshadern, Munich, Germany
W
W
Klepetko
M
M
Estenne
A
A
Glanville
G
G
Verleden
J D.
JD
Aubert
K
K
Sarahrudi
M
M
Gerbase
S
S
Hirt
H
H
Reichenspurner
M
M
Ploner